Natixis’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.19M | Buy |
|
|||||
|
2025
Q2 | $1.05M | Buy |
|
|||||
|
2025
Q1 | $444K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $684K | Sell |
|
|||||
|
2024
Q2 | $773K | Sell |
|
|||||
|
2024
Q1 | $1.06M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $953K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $6.03M | Buy |
|
|||||
|
2022
Q2 | $605K | Sell |
|
|||||
|
2022
Q1 | $13M | Buy |
|
|||||
|
2021
Q4 | $5.72M | Buy |
|
|||||
|
2021
Q3 | $5.21M | Buy |
|
|||||
|
2021
Q2 | $2.21M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $8.36M | Sell |
|
|||||
|
2019
Q4 | $11M | Sell |
|
|||||
|
2019
Q3 | $14.3M | Buy |
|
|||||
|
2019
Q2 | $5.47M | Sell |
|
|||||
|
2019
Q1 | $20.6M | Buy |
|
|||||
|
2018
Q4 | $5.77M | Sell |
|
|||||
|
2018
Q3 | $11.5M | Buy |
|
|||||
|
2018
Q2 | $4.83M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $338K | Sell |
|
|||||
|
2017
Q2 | $321K | Buy |
|
|||||
|
2017
Q1 | $277K | Buy |
|